Literature DB >> 18727711

Anaemia and marrow fibrosis in patients with primary hyperparathyroidism before and after curative parathyroidectomy.

Sanjay K Bhadada1, Anil Bhansali, Jasmina Ahluwalia, G V Chanukya, Arunanshu Behera, Pinaki Dutta.   

Abstract

OBJECTIVE: To determine the relationship between anaemia and myelofibrosis in patients with symptomatic primary hyperparathyroidism (PHPT) and to assess the effect of curative parathyroidectomy on anaemia and marrow fibrosis. DESIGN AND METHODS: In this prospective follow-up study of 28 consecutive patients with symptomatic PHPT from January 2005 to June 2006, 15 patients were diagnosed with anaemia (haemoglobin < 130 g/l in males and < 120 g/l in females), eight (53%) of whom were finally recruited for the study. Complete blood cell count, serum calcium, phosphorus, alkaline phosphatase, intact PTH and 25-hydroxyvitamin D and bone marrow examination were performed both before and after parathyroidectomy in all (n = 8) patients, but bone marrow examination after surgery was performed only in those who had marrow fibrosis at baseline (n = 6).
RESULTS: Anaemia was observed in 15 (53.3%) of the 28 patients with symptomatic PHPT. Normocytic normochromic anaemia that is characteristic of PHPT was found in 14 (50%) patients. Eight of the 15 patients with anaemia had a bone marrow examination and marrow fibrosis was observed in six (75%). Both anaemia and marrow fibrosis improved after successful parathyroidectomy, but improvement in anaemia was significant (P = 0.02) only in those with marrow fibrosis at baseline. Marrow fibrosis did not correlate with duration of the disease (P = 0.17), degree of hypercalcaemia (P = 0.53) or serum levels of intact PTH (P = 0.60).
CONCLUSIONS: Anaemia is common in patients with symptomatic PHPT, and was associated with marrow fibrosis in the majority of the patients who underwent bone biopsy. Both anaemia and marrow fibrosis improved after curative parathyroidectomy, but improvement in anaemia was noticeable only in those who had marrow fibrosis at presentation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18727711     DOI: 10.1111/j.1365-2265.2008.03346.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  13 in total

1.  Primary hyperparathyroidism associated to thrombocytopenia: an issue to consider?

Authors:  Steven De Keukeleire; Kristoff Muylle; Georgios Tsoumalis; Stefan Vermeulen; Dirk Vogelaers
Journal:  Clin Cases Miner Bone Metab       Date:  2017-05-30

2.  Metabolic bone disease: Newer perspectives.

Authors:  Anil Bhansali
Journal:  Indian J Endocrinol Metab       Date:  2012-12

3.  Study of Red Cell Fragility in Different Stages of Chronic Kidney Disease in Relation to Parathyroid Hormone.

Authors:  Suchismita Panda; Anuva Mishra; Manoranjan Jena; Sashi Bhusan Rout; Srikrushna Mohapatra
Journal:  J Clin Diagn Res       Date:  2017-08-01

4.  Systematic review of primary hyperparathyroidism in India: the past, present, and the future trends.

Authors:  P V Pradeep; B Jayashree; Anjali Mishra; S K Mishra
Journal:  Int J Endocrinol       Date:  2011-05-26       Impact factor: 3.257

5.  The resolution of anemia after curative parathyroidectomy is sustained even after a decade.

Authors:  Sanjay Kumar Bhadada; Ashutosh Kumar Arya; Girish Parthan; Priyanka Singh
Journal:  Indian J Endocrinol Metab       Date:  2015 Sep-Oct

6.  Effects of Secondary Hyperparathyroidism Treatment on Improvement in Anemia: Results from the MBD-5D Study.

Authors:  Motoko Tanaka; Kazuki Yoshida; Shingo Fukuma; Kazuko Ito; Kazutaka Matsushita; Masafumi Fukagawa; Shunichi Fukuhara; Tadao Akizawa
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

7.  Association between neutrophil-to-lymphocyte ratio and parathyroid hormone in patients with primary hyperparathyroidism.

Authors:  Hung-Bun Lam; Po-Sheng Yang; Ming-Nan Chien; Jie-Jen Lee; Li-Fen Chao; Shih-Ping Cheng
Journal:  Arch Med Sci       Date:  2018-03-28       Impact factor: 3.318

8.  Myelofibrosis and Pancytopenia Associated With Primary Hyperparathyroidism.

Authors:  Remya Rajan; Immanuel Paul; Kripa Elizabeth Cherian; Anu Korula; Julie Hephzibah; Marie Therese Manipadam; Deepak Thomas Abraham; Nitin Kapoor; Thomas Vizhalil Paul
Journal:  AACE Clin Case Rep       Date:  2020-12-28

9.  Concurrent parathyroid carcinoma and adenoma: A rare presentation of a rarer disease entity.

Authors:  Shamita Chatterjee; Udipta Ray; Shahana Gupta; Arghya Basu
Journal:  Indian J Endocrinol Metab       Date:  2013-09

10.  Effect of vitamin D3 supplementation on iron status: a randomized, double-blind, placebo-controlled trial among ethnic minorities living in Norway.

Authors:  Ahmed A Madar; Lars C Stene; Haakon E Meyer; Mette Brekke; Per Lagerløv; Kirsten V Knutsen
Journal:  Nutr J       Date:  2016-08-09       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.